BioWorld

April 3, 2002

View Archived Issues

Kalypsys Raises $43M In First Round, Plans Platform Growth

Kalypsys Inc. raised $43 million in its first round of financing and will now look to grow the technology that gave it its start. (BioWorld Today) Read More

Microbia Gets $26M In Series C To Fund Anti-Infective Drugs

Read More

Maternal Autoantibodies Confer Type I Diabetes On Transgenic, Disease-Modeling NOD Embryo

Read More

Ambit Enters Collaboration With AstraZeneca On Protein Targets

Read More

Other News To Note

Read More